Phase II trial of GM-CSF as maintenance therapy post-autologous peripheral blood stem cell transplantation in multiple myeloma

被引：0
|
作者：
Mandanas, RA [1 ]
Beveridge, R [1 ]
Rifkin, RM [1 ]
Greenspan, AR [1 ]
Orloff, GJ [1 ]
Klein, LM [1 ]
Rauch, MA [1 ]
Boehm, KA [1 ]
Zhan, F [1 ]
Asmar, L [1 ]
机构：
[1] US Oncol Res Inc, Houston, TX USA
来源：
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION | 2005年 / 11卷 / 02期
关键词：
D O I：
10.1016/j.bbmt.2004.12.221
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
221
引用
收藏
页码：75 / 75
页数：1
相关论文
共 50 条
  • [1] CLINICAL OUTCOMES WITH AND WITHOUT SARGRAMOSTIM (GM-CSF) POST AUTOLOGOUS PERIPHERAL BLOOD STEM CELL TRANSPLANTATION
    Howle, E. L.
    Wolf, R. C.
    Burzynski, J. A.
    Gastinean, D. A.
    Lacy, M. Q.
    Gertz, M. A.
    Dispenzieri, A.
    Kumar, S.
    Dingli, D.
    Buadi, F.
    Inwards, D. J.
    Ansell, S. M.
    Micallef, I. N. M.
    Johnston, P. B.
    Porrata, L. F.
    Elliott, M. A.
    Hogan, W. J.
    Litzow, M. R.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2009, 15 (02) : 43 - 43
  • [2] Maintenance Strategies Post-Autologous Stem Cell Transplantation for Newly Diagnosed Multiple Myeloma
    Sarah Bird
    Graham Jackson
    Charlotte Pawlyn
    Clinical Hematology International, 2020, 2 (2) : 59 - 68
  • [3] COMBINATION OF IFN-/GM-CSF AS MAINTENANCE THERAPY FOR MULTIPLE MYELOMA PATIENTS AFTER AUTOLOGOUS STEM CELL TRANSPLANTATION (ASCT): RESULTS OF A PROSPECTIVE PHASE II STUDY
    Salmasinia, D.
    Moreb, J. S.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2009, 15 (02) : 68 - 68
  • [4] Combination of IFN-alpha/Gm-Csf as a Maintenance Therapy for Multiple Myeloma Patients After Autologous Stem Cell Transplantation (Asct): a Prospective Phase Ii Study
    Salmasinia, Donya
    Chang, Myron
    Wingard, John R.
    Hou, Wei
    Moreb, Jan S.
    CLINICAL MEDICINE INSIGHTS-ONCOLOGY, 2010, 4 : 117 - 125
  • [5] GM-CSF for peripheral blood stem cell harvest in myeloma
    Kelsey, SM
    Hazel, D
    Murrell, C
    Newland, AC
    BRITISH JOURNAL OF HAEMATOLOGY, 1996, 92 (02) : 505 - 505
  • [6] GM-CSF and interferon-α maintenance therapy for multiple myeloma patients after autologous stem cell transplantation (ASCT):: An interim report
    Gowda, S
    Cogle, CR
    Khan, SA
    Moreb, JS
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2005, 11 (02) : 75 - 76
  • [7] Real-world outcomes of maintenance therapy post-autologous stem cell transplantation in newly diagnosed multiple myeloma
    Kang, Ka-Won
    Kim, Dae Sik
    Lee, Se Ryeon
    Heo, Mi Hwa
    Eom, Hyeon-Seok
    Jung, Jongheon
    Lee, Ji Hyun
    Kim, Sung-Hyun
    Koh, Youngil
    Min, Chang-Ki
    Lee, Seung Shin
    Lim, Sung-Nam
    Yhim, Ho-Young
    Lee, Myung-won
    Lee, Je-Jung
    Jung, Sung-Hoon
    Bang, Soo-Mee
    Kim, Kihyun
    BMC CANCER, 2025, 25 (01)
  • [8] Phase II Study of Iberdomide Maintenance Therapy Post-Autologous Stem Cell Transplant in Multiple Myeloma: Results of a Planned Interim Analysis
    Wildes, Tanya
    Suman, Vera Jean
    Strege, Marnee
    Tario, Joseph
    Holstein, Sarah
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 : S32 - S32
  • [9] Post-Autologous Stem Cell Transplantation Therapy for Multiple Myeloma Patients: Impact on Clinical Outcomes
    Jimenez-Zepeda, Victor
    Duggan, Peter
    Neri, Paola
    Tay, Jason
    McCulloch, Sylvia
    Bahlis, Nizar J.
    BLOOD, 2017, 130
  • [10] Preliminary Results of a Phase II Study of Lenalidomide-Elotuzumab As Maintenance Therapy Post-Autologous Stem Cell Transplant in Patients with Multiple Myeloma
    Thomas, Sheeba K.
    Shah, Jatin J.
    Lee, Hans C.
    Manasanch, Elisabet E.
    Weber, Donna M.
    Patel, Krina K.
    Feng, Lei
    Amini, Behrang
    Morphey, Ashley
    Crumpton, Brandon
    Phillips, Suzanne
    Miller, Carla
    Gonzalez, Mariann
    Orlowski, Robert Z.
    BLOOD, 2017, 130
12345